s6y Humacyte, Inc. EFFECT

Humacyte, Inc. EFFECT, filed Mar 31, 2022: primary_doc.xml

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: March 31, 2022
Accession Number: 0001818382-22-000014
Submission Type: POS AM
CIK: 0001818382
Company Name: Humacyte, Inc.
File Number: 333-259624